Assyro AI

FDA Orange Book · active-ingredient family

Metyrosine

Metyrosine is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:DEMSER · NDA 017871

1

Brand (NDA)

3

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule

ProductApplicantApplicationTEApproved
DEMSERRLDBAUSCHNDA 017871ABApproved Prior to Jan 1, 1982

Generic (ANDA) products (3)

ProductApplicantApplicationTEApproved
METYROSINEDR REDDYS LABS SAANDA 218620ABApr 09, 2025
METYROSINELEADINGANDA 215541ABSep 17, 2024
METYROSINEAMNEALANDA 213734ABJul 24, 2020

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Metyrosine — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.